beta-interferon (Intranasal Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebeta-interferon (Intranasal Therapeutics)
Drug Alias Namebeta-interferon (Intranasal Technology)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIkano Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIkano Therapeutics
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A